Related Experiment Video
Updated: May 14, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.4K
Artificial Intelligence in Histopathological Analysis for Predicting Immunotherapy Response in Cutaneous Melanoma
1Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
International Journal of Molecular Sciences
|November 13, 2025
Summary
Artificial intelligence (AI) enhances melanoma prognosis by automating tumor-infiltrating lymphocyte (TIL) analysis. AI-powered spatial profiling of TILs improves prediction of immunotherapy response, offering a more objective and comprehensive approach.
Area of Science:
- Oncology
- Computational Pathology
- Immunology
Background:
- Manual assessment of tumor-infiltrating lymphocytes (TILs) in cutaneous melanoma is subjective and labor-intensive.
- TILs are crucial prognostic markers, but their accurate quantification is challenging.
- Existing methods often analyze limited tissue areas, missing comprehensive immune microenvironment insights.
Purpose of the Study:
- To review advancements in AI-driven histopathology for cutaneous melanoma.
- To highlight automated TIL quantification and spatial immune profiling methods.
- To demonstrate how AI refines prognostic evaluation and predicts immunotherapy outcomes.
Main Methods:
- AI algorithms for automated TIL density quantification.
- Spatial immune profiling using whole-slide imaging analysis.
- Review of studies applying AI to melanoma histopathology and immunotherapy response prediction.
Main Results:
- AI enables reproducible and objective TIL quantification across entire slides.
- Spatially resolved TIL profiling shows strong potential as a prognostic and predictive biomarker.
- AI-driven analysis improves the understanding of the tumor immune microenvironment in melanoma.
Conclusions:
- AI transforms melanoma histopathology by automating complex analyses.
- Automated TIL quantification and spatial profiling enhance prognostic accuracy.
- AI innovations are key to optimizing immunotherapy selection and predicting patient outcomes.

